ChemoCentryx
CCXI
#3816
Rank
S$4.75 B
Marketcap
S$66.08
Share price
0.00%
Change (1 day)
32.41%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI.defunct)

Last known market cap: S$4.75 Billion

On November 25, 2022 ChemoCentryx had a market cap of S$4.75 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022S$5.01 B45.41%
2021S$3.44 B-39.2%
2020S$5.66 B76.52%
2019S$3.21 B325.42%
2018S$0.75 B94.53%
2017S$0.38 B-24.2%
2016S$0.51 B1.13%
2015S$0.50 B29.12%
2014S$0.39 B24.62%
2013S$0.31 B-35.31%
2012S$0.48 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$814.29 B 17,034.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$206.17 B 4,238.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$575.92 B 12,018.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$295.38 B 6,115.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$40.68 B 756.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$463.34 B 9,649.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$173.45 B 3,549.90%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$127.91 B 2,591.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$53.39 B 1,023.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel